| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 4.95B | 5.13B | 6.02B | 16.07B | 11.44B | 9.71B |
| Gross Profit | 1.05B | 1.15B | 1.38B | 4.03B | 2.93B | 2.51B |
| EBITDA | 676.00M | 805.00M | 1.31B | 1.36B | 1.95B | 1.75B |
| Net Income | 139.00M | 223.00M | 2.09B | 1.91B | 948.00M | -1.09B |
Balance Sheet | ||||||
| Total Assets | 6.30B | 6.69B | 7.02B | 20.66B | 20.05B | 16.79B |
| Cash, Cash Equivalents and Short-Term Investments | 345.00M | 555.00M | 711.00M | 1.69B | 2.27B | 1.22B |
| Total Debt | 2.23B | 1.88B | 2.19B | 2.96B | 3.35B | 3.51B |
| Total Liabilities | 5.09B | 5.29B | 5.72B | 10.00B | 11.20B | 9.49B |
| Stockholders Equity | 1.14B | 1.34B | 1.26B | 10.60B | 8.74B | 7.20B |
Cash Flow | ||||||
| Free Cash Flow | 243.00M | 330.00M | 847.00M | 1.10B | 863.00M | 707.00M |
| Operating Cash Flow | 548.00M | 615.00M | 1.91B | 2.01B | 1.50B | 1.24B |
| Investing Cash Flow | -284.00M | -281.00M | -1.79B | -831.00M | -470.00M | 711.00M |
| Financing Cash Flow | -397.00M | -364.00M | -455.00M | -1.19B | -1.10B | -1.69B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| ― | $3.48B | 23.30 | 10.62% | 9.59% | -28.95% | -92.43% | |
| ― | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
| ― | $1.57B | ― | -10.43% | 11.05% | -1.56% | -259.58% | |
| ― | $18.04B | ― | -6.39% | 9.65% | -5.25% | -208.14% | |
| ― | $4.62B | ― | -25.69% | 0.29% | -5.83% | -183.85% | |
| ― | $588.13M | ― | -14.11% | 11.46% | 0.20% | -292.54% | |
| ― | $1.10B | ― | ― | ― | -3.33% | 44.37% |
Solvay’s recent earnings call painted a mixed picture, with significant challenges in the soda ash and Coatis markets due to geopolitical tensions and competitive pressures. These difficulties have led to a decline in net sales and EBITDA. However, the company showcased resilience in its Performance Chemicals segment and highlighted promising opportunities in the rare earths business. Despite these positive aspects, the negative trends in key segments cast a shadow over the overall outlook.
Solvay SA is a global chemical company operating in sectors such as chemicals and advanced materials, known for its innovation and sustainability initiatives. In its latest earnings report for the second quarter and first half of 2025, Solvay reported a decline in net sales and EBITDA due to a challenging market environment influenced by geopolitical tensions and tariff issues. Key financial metrics showed a decrease in net sales by 7.8% and EBITDA by 15.4% in Q2 2025 compared to the previous year, with free cash flow also significantly reduced. Despite these challenges, Solvay achieved structural cost savings and maintained a solid EBITDA margin of 20.9%. The company has adjusted its 2025 outlook, expecting EBITDA between €880 million and €930 million and confirming a free cash flow target of around €300 million. Solvay remains committed to disciplined investments and cash generation, reflecting a cautious but determined approach to navigating current market conditions.